nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—ganglion—brain cancer	0.0508	0.326	CbGeAlD
Regadenoson—Azacitidine—DNMT1—brain cancer	0.0318	0.691	CrCbGaD
Regadenoson—Haemorrhage intracranial—Temozolomide—brain cancer	0.0208	0.0261	CcSEcCtD
Regadenoson—ADORA2A—telencephalon—brain cancer	0.0196	0.126	CbGeAlD
Regadenoson—Altered state of consciousness—Temozolomide—brain cancer	0.0185	0.0232	CcSEcCtD
Regadenoson—Faecal incontinence—Carmustine—brain cancer	0.0175	0.0219	CcSEcCtD
Regadenoson—Transient ischaemic attack—Temozolomide—brain cancer	0.0169	0.0212	CcSEcCtD
Regadenoson—Faecal incontinence—Temozolomide—brain cancer	0.0169	0.0212	CcSEcCtD
Regadenoson—ADORA2A—gonad—brain cancer	0.0163	0.105	CbGeAlD
Regadenoson—Adenosine triphosphate—ALK—brain cancer	0.0142	0.309	CrCbGaD
Regadenoson—Throat tightness—Etoposide—brain cancer	0.0139	0.0174	CcSEcCtD
Regadenoson—ADORA2A—spinal cord—brain cancer	0.0137	0.0881	CbGeAlD
Regadenoson—ADORA2A—endocrine gland—brain cancer	0.0124	0.0793	CbGeAlD
Regadenoson—Renal failure—Lomustine—brain cancer	0.0122	0.0153	CcSEcCtD
Regadenoson—ADORA2A—head—brain cancer	0.0122	0.0783	CbGeAlD
Regadenoson—ADORA2A—central nervous system—brain cancer	0.0111	0.0714	CbGeAlD
Regadenoson—ADORA2A—cerebellum—brain cancer	0.0109	0.0698	CbGeAlD
Regadenoson—Injection site pain—Carmustine—brain cancer	0.0108	0.0135	CcSEcCtD
Regadenoson—ADORA2A—brain—brain cancer	0.00884	0.0567	CbGeAlD
Regadenoson—Musculoskeletal pain—Temozolomide—brain cancer	0.00864	0.0108	CcSEcCtD
Regadenoson—Angina pectoris—Procarbazine—brain cancer	0.00862	0.0108	CcSEcCtD
Regadenoson—Depressed level of consciousness—Carmustine—brain cancer	0.00853	0.0107	CcSEcCtD
Regadenoson—Depressed level of consciousness—Temozolomide—brain cancer	0.00824	0.0103	CcSEcCtD
Regadenoson—Pain—Carboplatin—brain cancer	0.00775	0.00971	CcSEcCtD
Regadenoson—Chest discomfort—Etoposide—brain cancer	0.00772	0.00967	CcSEcCtD
Regadenoson—Eye pain—Carmustine—brain cancer	0.0071	0.00889	CcSEcCtD
Regadenoson—Eye pain—Temozolomide—brain cancer	0.00686	0.0086	CcSEcCtD
Regadenoson—Flushing—Procarbazine—brain cancer	0.00658	0.00824	CcSEcCtD
Regadenoson—Tremor—Procarbazine—brain cancer	0.00578	0.00724	CcSEcCtD
Regadenoson—Syncope—Procarbazine—brain cancer	0.00553	0.00693	CcSEcCtD
Regadenoson—Loss of consciousness—Procarbazine—brain cancer	0.00542	0.00679	CcSEcCtD
Regadenoson—Abdominal distension—Temozolomide—brain cancer	0.00539	0.00675	CcSEcCtD
Regadenoson—Cough—Procarbazine—brain cancer	0.00538	0.00674	CcSEcCtD
Regadenoson—Convulsion—Procarbazine—brain cancer	0.00534	0.0067	CcSEcCtD
Regadenoson—Hypertension—Procarbazine—brain cancer	0.00533	0.00667	CcSEcCtD
Regadenoson—Myalgia—Procarbazine—brain cancer	0.00525	0.00658	CcSEcCtD
Regadenoson—Arthralgia—Procarbazine—brain cancer	0.00525	0.00658	CcSEcCtD
Regadenoson—Anxiety—Procarbazine—brain cancer	0.00523	0.00656	CcSEcCtD
Regadenoson—Vomiting—Lomustine—brain cancer	0.00504	0.00632	CcSEcCtD
Regadenoson—Angiopathy—Hydroxyurea—brain cancer	0.00498	0.00623	CcSEcCtD
Regadenoson—Shock—Procarbazine—brain cancer	0.00495	0.00621	CcSEcCtD
Regadenoson—Tachycardia—Procarbazine—brain cancer	0.00491	0.00616	CcSEcCtD
Regadenoson—Hyperhidrosis—Procarbazine—brain cancer	0.00487	0.0061	CcSEcCtD
Regadenoson—Renal failure—Carmustine—brain cancer	0.00485	0.00608	CcSEcCtD
Regadenoson—Erythema—Hydroxyurea—brain cancer	0.00477	0.00598	CcSEcCtD
Regadenoson—Cardiac arrest—Etoposide—brain cancer	0.00471	0.0059	CcSEcCtD
Regadenoson—Nausea—Lomustine—brain cancer	0.00471	0.0059	CcSEcCtD
Regadenoson—Hypotension—Procarbazine—brain cancer	0.0047	0.00589	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00459	0.00575	CcSEcCtD
Regadenoson—Insomnia—Procarbazine—brain cancer	0.00455	0.00571	CcSEcCtD
Regadenoson—Paraesthesia—Procarbazine—brain cancer	0.00452	0.00566	CcSEcCtD
Regadenoson—Somnolence—Procarbazine—brain cancer	0.00448	0.00561	CcSEcCtD
Regadenoson—Ill-defined disorder—Hydroxyurea—brain cancer	0.00443	0.00555	CcSEcCtD
Regadenoson—Hypoaesthesia—Carmustine—brain cancer	0.00441	0.00553	CcSEcCtD
Regadenoson—Connective tissue disorder—Carmustine—brain cancer	0.00436	0.00546	CcSEcCtD
Regadenoson—Malaise—Hydroxyurea—brain cancer	0.00431	0.00539	CcSEcCtD
Regadenoson—Pain—Procarbazine—brain cancer	0.00431	0.00539	CcSEcCtD
Regadenoson—Hypoaesthesia—Temozolomide—brain cancer	0.00426	0.00534	CcSEcCtD
Regadenoson—Bronchospasm—Etoposide—brain cancer	0.00421	0.00528	CcSEcCtD
Regadenoson—Connective tissue disorder—Temozolomide—brain cancer	0.00421	0.00528	CcSEcCtD
Regadenoson—Feeling abnormal—Procarbazine—brain cancer	0.00415	0.0052	CcSEcCtD
Regadenoson—Eye disorder—Carmustine—brain cancer	0.00414	0.00519	CcSEcCtD
Regadenoson—Convulsion—Hydroxyurea—brain cancer	0.00414	0.00518	CcSEcCtD
Regadenoson—Gastrointestinal pain—Procarbazine—brain cancer	0.00412	0.00516	CcSEcCtD
Regadenoson—Flushing—Carmustine—brain cancer	0.00411	0.00516	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00404	0.00506	CcSEcCtD
Regadenoson—Discomfort—Hydroxyurea—brain cancer	0.00402	0.00503	CcSEcCtD
Regadenoson—Eye disorder—Temozolomide—brain cancer	0.004	0.00502	CcSEcCtD
Regadenoson—Urticaria—Procarbazine—brain cancer	0.004	0.00501	CcSEcCtD
Regadenoson—Tinnitus—Temozolomide—brain cancer	0.00399	0.00501	CcSEcCtD
Regadenoson—Abdominal pain—Procarbazine—brain cancer	0.00398	0.00499	CcSEcCtD
Regadenoson—Flushing—Temozolomide—brain cancer	0.00398	0.00498	CcSEcCtD
Regadenoson—Cardiac disorder—Temozolomide—brain cancer	0.00398	0.00498	CcSEcCtD
Regadenoson—Angiopathy—Temozolomide—brain cancer	0.00389	0.00487	CcSEcCtD
Regadenoson—Mental disorder—Carmustine—brain cancer	0.00388	0.00487	CcSEcCtD
Regadenoson—Immune system disorder—Temozolomide—brain cancer	0.00387	0.00485	CcSEcCtD
Regadenoson—Mediastinal disorder—Temozolomide—brain cancer	0.00386	0.00484	CcSEcCtD
Regadenoson—Erythema—Carmustine—brain cancer	0.00386	0.00484	CcSEcCtD
Regadenoson—Nervous system disorder—Hydroxyurea—brain cancer	0.00382	0.00479	CcSEcCtD
Regadenoson—Skin disorder—Hydroxyurea—brain cancer	0.00378	0.00474	CcSEcCtD
Regadenoson—Acute coronary syndrome—Etoposide—brain cancer	0.00376	0.00472	CcSEcCtD
Regadenoson—Renal failure—Etoposide—brain cancer	0.00375	0.0047	CcSEcCtD
Regadenoson—Mental disorder—Temozolomide—brain cancer	0.00375	0.0047	CcSEcCtD
Regadenoson—Myocardial infarction—Etoposide—brain cancer	0.00374	0.00469	CcSEcCtD
Regadenoson—Erythema—Temozolomide—brain cancer	0.00373	0.00467	CcSEcCtD
Regadenoson—Hypersensitivity—Procarbazine—brain cancer	0.00371	0.00465	CcSEcCtD
Regadenoson—Dysgeusia—Temozolomide—brain cancer	0.00365	0.00458	CcSEcCtD
Regadenoson—Vision blurred—Carmustine—brain cancer	0.00364	0.00456	CcSEcCtD
Regadenoson—Tremor—Carmustine—brain cancer	0.00362	0.00453	CcSEcCtD
Regadenoson—Asthenia—Procarbazine—brain cancer	0.00361	0.00453	CcSEcCtD
Regadenoson—Vision blurred—Temozolomide—brain cancer	0.00352	0.0044	CcSEcCtD
Regadenoson—Tremor—Temozolomide—brain cancer	0.00349	0.00438	CcSEcCtD
Regadenoson—Dyspnoea—Hydroxyurea—brain cancer	0.00347	0.00435	CcSEcCtD
Regadenoson—Somnolence—Hydroxyurea—brain cancer	0.00346	0.00434	CcSEcCtD
Regadenoson—Ill-defined disorder—Temozolomide—brain cancer	0.00346	0.00434	CcSEcCtD
Regadenoson—Diarrhoea—Procarbazine—brain cancer	0.00344	0.00432	CcSEcCtD
Regadenoson—Hypoaesthesia—Etoposide—brain cancer	0.00341	0.00427	CcSEcCtD
Regadenoson—Angioedema—Temozolomide—brain cancer	0.00341	0.00427	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00336	0.00421	CcSEcCtD
Regadenoson—Malaise—Temozolomide—brain cancer	0.00336	0.00421	CcSEcCtD
Regadenoson—Convulsion—Carmustine—brain cancer	0.00334	0.00419	CcSEcCtD
Regadenoson—Hypertension—Carmustine—brain cancer	0.00333	0.00418	CcSEcCtD
Regadenoson—Pain—Hydroxyurea—brain cancer	0.00333	0.00417	CcSEcCtD
Regadenoson—Dizziness—Procarbazine—brain cancer	0.00333	0.00417	CcSEcCtD
Regadenoson—Palpitations—Temozolomide—brain cancer	0.0033	0.00413	CcSEcCtD
Regadenoson—Chest pain—Carmustine—brain cancer	0.00329	0.00412	CcSEcCtD
Regadenoson—Myalgia—Carmustine—brain cancer	0.00329	0.00412	CcSEcCtD
Regadenoson—Anxiety—Carmustine—brain cancer	0.00327	0.0041	CcSEcCtD
Regadenoson—Cough—Temozolomide—brain cancer	0.00325	0.00408	CcSEcCtD
Regadenoson—Convulsion—Temozolomide—brain cancer	0.00323	0.00405	CcSEcCtD
Regadenoson—Hypertension—Temozolomide—brain cancer	0.00322	0.00403	CcSEcCtD
Regadenoson—Feeling abnormal—Hydroxyurea—brain cancer	0.00321	0.00402	CcSEcCtD
Regadenoson—Eye disorder—Etoposide—brain cancer	0.0032	0.00401	CcSEcCtD
Regadenoson—Vomiting—Procarbazine—brain cancer	0.0032	0.00401	CcSEcCtD
Regadenoson—Cardiac disorder—Etoposide—brain cancer	0.00318	0.00399	CcSEcCtD
Regadenoson—Flushing—Etoposide—brain cancer	0.00318	0.00399	CcSEcCtD
Regadenoson—Arthralgia—Temozolomide—brain cancer	0.00318	0.00398	CcSEcCtD
Regadenoson—Myalgia—Temozolomide—brain cancer	0.00318	0.00398	CcSEcCtD
Regadenoson—Rash—Procarbazine—brain cancer	0.00317	0.00398	CcSEcCtD
Regadenoson—Dermatitis—Procarbazine—brain cancer	0.00317	0.00397	CcSEcCtD
Regadenoson—Anxiety—Temozolomide—brain cancer	0.00316	0.00396	CcSEcCtD
Regadenoson—Headache—Procarbazine—brain cancer	0.00315	0.00395	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00315	0.00395	CcSEcCtD
Regadenoson—Discomfort—Temozolomide—brain cancer	0.00314	0.00393	CcSEcCtD
Regadenoson—Angiopathy—Etoposide—brain cancer	0.00311	0.0039	CcSEcCtD
Regadenoson—Immune system disorder—Etoposide—brain cancer	0.0031	0.00388	CcSEcCtD
Regadenoson—Mediastinal disorder—Etoposide—brain cancer	0.00309	0.00387	CcSEcCtD
Regadenoson—Tachycardia—Carmustine—brain cancer	0.00307	0.00385	CcSEcCtD
Regadenoson—Anaphylactic shock—Temozolomide—brain cancer	0.00304	0.00381	CcSEcCtD
Regadenoson—Nausea—Procarbazine—brain cancer	0.00299	0.00375	CcSEcCtD
Regadenoson—Nervous system disorder—Temozolomide—brain cancer	0.00299	0.00374	CcSEcCtD
Regadenoson—Skin disorder—Temozolomide—brain cancer	0.00296	0.0037	CcSEcCtD
Regadenoson—Hypotension—Carmustine—brain cancer	0.00294	0.00369	CcSEcCtD
Regadenoson—Hyperhidrosis—Temozolomide—brain cancer	0.00294	0.00369	CcSEcCtD
Regadenoson—Dysgeusia—Etoposide—brain cancer	0.00292	0.00366	CcSEcCtD
Regadenoson—Hypersensitivity—Hydroxyurea—brain cancer	0.00287	0.0036	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Carmustine—brain cancer	0.00287	0.0036	CcSEcCtD
Regadenoson—Insomnia—Carmustine—brain cancer	0.00285	0.00357	CcSEcCtD
Regadenoson—Paraesthesia—Carmustine—brain cancer	0.00283	0.00354	CcSEcCtD
Regadenoson—Dyspnoea—Carmustine—brain cancer	0.00281	0.00352	CcSEcCtD
Regadenoson—Somnolence—Carmustine—brain cancer	0.0028	0.00351	CcSEcCtD
Regadenoson—Asthenia—Hydroxyurea—brain cancer	0.0028	0.0035	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00277	0.00347	CcSEcCtD
Regadenoson—Ill-defined disorder—Etoposide—brain cancer	0.00277	0.00347	CcSEcCtD
Regadenoson—Insomnia—Temozolomide—brain cancer	0.00275	0.00345	CcSEcCtD
Regadenoson—Paraesthesia—Temozolomide—brain cancer	0.00273	0.00342	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Carmustine—brain cancer	0.00272	0.00341	CcSEcCtD
Regadenoson—Dyspnoea—Temozolomide—brain cancer	0.00271	0.0034	CcSEcCtD
Regadenoson—Somnolence—Temozolomide—brain cancer	0.00271	0.00339	CcSEcCtD
Regadenoson—Pain—Carmustine—brain cancer	0.00269	0.00338	CcSEcCtD
Regadenoson—Malaise—Etoposide—brain cancer	0.00269	0.00337	CcSEcCtD
Regadenoson—Diarrhoea—Hydroxyurea—brain cancer	0.00267	0.00334	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Temozolomide—brain cancer	0.00263	0.00329	CcSEcCtD
Regadenoson—Loss of consciousness—Etoposide—brain cancer	0.00262	0.00329	CcSEcCtD
Regadenoson—Cough—Etoposide—brain cancer	0.0026	0.00326	CcSEcCtD
Regadenoson—Pain—Temozolomide—brain cancer	0.0026	0.00326	CcSEcCtD
Regadenoson—Feeling abnormal—Carmustine—brain cancer	0.0026	0.00325	CcSEcCtD
Regadenoson—Convulsion—Etoposide—brain cancer	0.00259	0.00324	CcSEcCtD
Regadenoson—Hypertension—Etoposide—brain cancer	0.00258	0.00323	CcSEcCtD
Regadenoson—Dizziness—Hydroxyurea—brain cancer	0.00258	0.00323	CcSEcCtD
Regadenoson—Gastrointestinal pain—Carmustine—brain cancer	0.00258	0.00323	CcSEcCtD
Regadenoson—Chest pain—Etoposide—brain cancer	0.00254	0.00318	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00252	0.00316	CcSEcCtD
Regadenoson—Discomfort—Etoposide—brain cancer	0.00251	0.00315	CcSEcCtD
Regadenoson—Feeling abnormal—Temozolomide—brain cancer	0.00251	0.00314	CcSEcCtD
Regadenoson—Abdominal pain—Carmustine—brain cancer	0.00249	0.00312	CcSEcCtD
Regadenoson—Gastrointestinal pain—Temozolomide—brain cancer	0.00249	0.00312	CcSEcCtD
Regadenoson—Vomiting—Hydroxyurea—brain cancer	0.00248	0.0031	CcSEcCtD
Regadenoson—Rash—Hydroxyurea—brain cancer	0.00246	0.00308	CcSEcCtD
Regadenoson—Dermatitis—Hydroxyurea—brain cancer	0.00245	0.00308	CcSEcCtD
Regadenoson—Headache—Hydroxyurea—brain cancer	0.00244	0.00306	CcSEcCtD
Regadenoson—Anaphylactic shock—Etoposide—brain cancer	0.00244	0.00305	CcSEcCtD
Regadenoson—Urticaria—Temozolomide—brain cancer	0.00242	0.00303	CcSEcCtD
Regadenoson—Abdominal pain—Temozolomide—brain cancer	0.00241	0.00302	CcSEcCtD
Regadenoson—Tachycardia—Etoposide—brain cancer	0.00238	0.00298	CcSEcCtD
Regadenoson—Skin disorder—Etoposide—brain cancer	0.00237	0.00296	CcSEcCtD
Regadenoson—Hyperhidrosis—Etoposide—brain cancer	0.00235	0.00295	CcSEcCtD
Regadenoson—Hypersensitivity—Carmustine—brain cancer	0.00232	0.00291	CcSEcCtD
Regadenoson—Nausea—Hydroxyurea—brain cancer	0.00231	0.0029	CcSEcCtD
Regadenoson—Hypotension—Etoposide—brain cancer	0.00228	0.00285	CcSEcCtD
Regadenoson—Asthenia—Carmustine—brain cancer	0.00226	0.00283	CcSEcCtD
Regadenoson—Hypersensitivity—Temozolomide—brain cancer	0.00224	0.00281	CcSEcCtD
Regadenoson—Paraesthesia—Etoposide—brain cancer	0.00219	0.00274	CcSEcCtD
Regadenoson—Asthenia—Temozolomide—brain cancer	0.00218	0.00274	CcSEcCtD
Regadenoson—Dyspnoea—Etoposide—brain cancer	0.00217	0.00272	CcSEcCtD
Regadenoson—Somnolence—Etoposide—brain cancer	0.00217	0.00271	CcSEcCtD
Regadenoson—Diarrhoea—Carmustine—brain cancer	0.00216	0.0027	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Etoposide—brain cancer	0.0021	0.00263	CcSEcCtD
Regadenoson—Dizziness—Carmustine—brain cancer	0.00208	0.00261	CcSEcCtD
Regadenoson—Pain—Etoposide—brain cancer	0.00208	0.00261	CcSEcCtD
Regadenoson—Diarrhoea—Temozolomide—brain cancer	0.00208	0.00261	CcSEcCtD
Regadenoson—Dizziness—Temozolomide—brain cancer	0.00201	0.00252	CcSEcCtD
Regadenoson—Feeling abnormal—Etoposide—brain cancer	0.00201	0.00252	CcSEcCtD
Regadenoson—Vomiting—Carmustine—brain cancer	0.002	0.00251	CcSEcCtD
Regadenoson—Gastrointestinal pain—Etoposide—brain cancer	0.00199	0.0025	CcSEcCtD
Regadenoson—Rash—Carmustine—brain cancer	0.00199	0.00249	CcSEcCtD
Regadenoson—Dermatitis—Carmustine—brain cancer	0.00198	0.00249	CcSEcCtD
Regadenoson—Headache—Carmustine—brain cancer	0.00197	0.00247	CcSEcCtD
Regadenoson—Vomiting—Temozolomide—brain cancer	0.00194	0.00243	CcSEcCtD
Regadenoson—Urticaria—Etoposide—brain cancer	0.00194	0.00242	CcSEcCtD
Regadenoson—Abdominal pain—Etoposide—brain cancer	0.00193	0.00241	CcSEcCtD
Regadenoson—Rash—Temozolomide—brain cancer	0.00192	0.0024	CcSEcCtD
Regadenoson—Dermatitis—Temozolomide—brain cancer	0.00192	0.0024	CcSEcCtD
Regadenoson—Headache—Temozolomide—brain cancer	0.00191	0.00239	CcSEcCtD
Regadenoson—Nausea—Carmustine—brain cancer	0.00187	0.00234	CcSEcCtD
Regadenoson—Nausea—Temozolomide—brain cancer	0.00181	0.00227	CcSEcCtD
Regadenoson—Hypersensitivity—Etoposide—brain cancer	0.00179	0.00225	CcSEcCtD
Regadenoson—Asthenia—Etoposide—brain cancer	0.00175	0.00219	CcSEcCtD
Regadenoson—Diarrhoea—Etoposide—brain cancer	0.00167	0.00209	CcSEcCtD
Regadenoson—Dizziness—Etoposide—brain cancer	0.00161	0.00202	CcSEcCtD
Regadenoson—Vomiting—Etoposide—brain cancer	0.00155	0.00194	CcSEcCtD
Regadenoson—Rash—Etoposide—brain cancer	0.00154	0.00192	CcSEcCtD
Regadenoson—Dermatitis—Etoposide—brain cancer	0.00153	0.00192	CcSEcCtD
Regadenoson—Headache—Etoposide—brain cancer	0.00153	0.00191	CcSEcCtD
Regadenoson—Nausea—Etoposide—brain cancer	0.00145	0.00181	CcSEcCtD
